NanaBis™

Medlab study shows NanaBis™ safe and well-tolerated for long-term use

Ritchelle Drilon Jan 17, 2023

Medlab Clinical Ltd is pleased to announce the interim results of its research on NanaBis™, a pharmaceutical-grade cannabis medicine for managing cancer-related and non-cancer related

0 Comment 1609 Views

Healthcare Channel – Sharing knowledge and resources for Australia’s health and aged care sector

How can we help?

MENU LINKS

EVENTS

WRITE FOR US

We always welcome thought leaders ready to mentor the next generation. Be a Healthcare Channel learning partner today!

Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.

Forgot your password?

Back to login

How composable technology can unlock healthcare’s digital opportunity

How can Internationally Educated Nurses adapt to the Australian healthcare environment?

AI to ease burdens for Australia’s healthcare sector

Disability doesn’t discriminate – the Government shouldn’t either

Satisfying more than just hunger: The FEAST revolution in aged care

Understanding the financial implications of recent and upcoming regulatory changes

The True Costs of Free Labour in Aged Care: An Industry Analysis

Transforming aged care culture: A dual focus on workforce psychology and digitisation

Millennials/Gen Z Aussies or Immigrants? Who Will Save Aged Care?

Speed up Your Hiring Process by Putting Worker Compliance Checks on Autopilot With New AI Made for Aged Care & Healthcare

Future-Proofing Aged Care: The Benefits of Employing Young People through Y Careers

The True Costs of Free Labour in Aged Care: An Industry Analysis

Call for My Health Record overhaul to improve GP and patient use

First-ever ADHD prescribing guide launched in Australia

Silverchain Group’s 130-year legacy in home care

Research sheds light on improving night shift productivity

LATEST EVENTS

6th Annual Aged Care Week

June 25, 2025

NanaBis™

How can we help?

MENU LINKS

EVENTS

FOLLOW US

WRITE FOR US